Felice H Schnoll-Sussman   Associate Professor of Clinical Medicine

  • +1 212 746 4014

Dr. Schnoll’s research interests are focused in the biology, genetics, prevention, diagnosis, and treatment of gastrointestinal malignancies.

Examples of Dr. Schnoll’s current research studies include: o Evaluation of green tea extract in the potential prevention of progression to esophageal cancer in patients with Barrett’s esophagus; o Evaluation of MRCP and EUS procedures as screening tools in the early detection of pancreatic cancer in people with a family history of this disease, along with collection and analysis of DNA from patients with pancreatic cancer and their families to identify potentially inherited genetic mutations that may contribute to the development of pancreatic cancer; o Analysis of biomarkers in the blood of people diagnosed with colorectal cancer, which could contribute to the development of improved and/or less invasive colon cancer screening; o Evaluation of confocal microendoscopy to determine whether this innovative technology improves the ability to detect small areas of precancerous cells in the GI tract.

Other research projects in development include the evaluation of the biology of pancreatic cysts and prevention of their progression to pancreatic cancer.

It is hoped that these promising areas of research will contribute to a greater understanding of the development of gastrointestinal cancers and ultimately to lifesaving advances in the prevention, diagnosis, and treatment of these diseases.


Sort by

Selected publications


Sort by

Grants awarded

  • Public Outreach of Colorectal Cancer Screening in Mammography Centers Principal Investigator 2008 - 2009
  • Next-Generation Sequencing to Evaluate Transciptomic Changes Associated with H. Pylori Infection and Gastric Cancer Carinogenesis Key Personnel 2012 - 2013
  • Self-Determination Theory and Lifestyle Behaviors in Barrett's Esophagus Patients  awarded by National Cancer Institute Principal Investigator Subaward 2011
  • A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multi-Center Study to Evaluate the Safety of the Co-administration Principal Investigator Subcontract 2006 - 2012
  • Phase Ib Study of Polyphenon E in Patients with Barrett's Esophagus Principal Investigator Subcontract 2006 - 2011
  • Phase IB Randomized Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients With Barrett's Esophagus Principal Investigator Subcontract 2005 - 2006



full name

  • Dr. Felice H Schnoll-Sussman,

primary email

  • fhs2001@med.cornell.edu


Primary Affiliation

  • Weill Cornell Medical College, Cornell University